Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $815 at Guggenheim

August 4, 2025 5:53 AM
Guggenheim analyst Yatin Suneja raised the price target on Regeneron Pharma (NASDAQ: REGN) to $815.00 (from $810.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles